Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer treatment …, 2019 - Elsevier
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, DA Reardon… - 2019 - lilloa.univ-lille.fr
Molecular targeted therapy of glioblastoma Toggle navigation English français Aide | Contact | À
Propos | Ouvrir une session Portail HAL | Pages Pro Chercheurs EN / FR Toggle navigation Voir …
Propos | Ouvrir une session Portail HAL | Pages Pro Chercheurs EN / FR Toggle navigation Voir …
[引用][C] Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, D Reardon… - Cancer Treatment …, 2019 - hal.science
Molecular targeted therapy of glioblastoma - Archive ouverte HAL Accéder directement au
contenu Documentation FR Français (FR) Anglais (EN) Se connecter HAL science ouverte …
contenu Documentation FR Français (FR) Anglais (EN) Se connecter HAL science ouverte …
Molecular targeted therapy of glioblastoma.
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer treatment …, 2019 - sonar.ch
English Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
[引用][C] Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer Treatment …, 2019 - cir.nii.ac.jp
Molecular targeted therapy of glioblastoma | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth… - Cancer …, 2019 - cancertreatmentreviews.com
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth… - Cancer treatment …, 2019 - pubmed.ncbi.nlm.nih.gov
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Molecular targeted therapy of glioblastoma.
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer treatment …, 2019 - folia.unifr.ch
English Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Molecular targeted therapy of glioblastoma.
E Le Rhun, M Preusser, P Roth… - Cancer Treatment …, 2019 - europepmc.org
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
Molecular targeted therapy of glioblastoma
E Le Rhun, M Preusser, P Roth, DA Reardon… - Cancer Treatment …, 2019 - zora.uzh.ch
Glioblastomas are intrinsic brain tumors thought to originate from neuroglial stem or
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …
progenitor cells. More than 90% of glioblastomas are isocitrate dehydrogenase (IDH) …